Von Eschenbach Nomination To Head FDA Already Mired In “Plan B” Politics
This article was originally published in The Gray Sheet
Executive Summary
No sooner did President Bush nominate Acting FDA Commissioner Andrew von Eschenbach March 15 to permanently head the agency than Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) announced they would place a hold on the nomination